Generalized granuloma annulare and hepatitis B vaccination.
As hepatitis B vaccination is becoming generalized in Europe, cutaneous adverse events are being more frequently reported in the literature. We report the first case of generalized granuloma annulare following hepatitis B immunization. A 51-year-old woman presented a generalized granuloma annulare one month after the one-year booster injection of the hepatitis B vaccine. The lesions resolved with sulfone therapy. We observed an identical recurrence three weeks after the five-year booster.
Wolf
F
F
Dermatology Department, Hôpital de l'Antiquaille, rue de l'Antiquaille, 69321 Lyon Cedex 05, France.
Grezard
P
P
Berard
F
F
Clavel
G
G
Perrot
H
H
D001415:Back; D001707:Biopsy, Needle; D005260:Female; D016460:Granuloma Annulare / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006509:Hepatitis B / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007117:Immunization, Secondary / Q000009:adverse effects*; D008875:Middle Aged; D012867:Skin / Q000473:pathology; D013450:Sulfones / Q000008:administration & dosage; D016896:Treatment Outcome
D017325:Hepatitis B Vaccines; D013450:Sulfones